medline.ch Onkologie Urologische Tumoren

	Body composition and renal cell carcinoma prognosis in elderly patients: a retrospective cohort study. BMC Urol Pajunen H, Veitonmäki T, Åkerla J, Aittoniemi A, Ronkainen J, Huhtala H, Nikkola J, Murtola TJ, Rinta-Kiikka I. PMID: 41998692 [PubMed - as supplied by publisher]
	Predicting clinically significant prostate cancer with or without digital rectal exam and MRI data using ClarityDX Prostate models. NPJ Digit Med Paproski RJ, Kinnaird A, Hyndman ME, Fairey A, Marks L, Pavlovich CP, Fletcher SA, Zachoval R, Adamcova V, Stejskal J, Aprikian A, Wallis CJD, Pink D, Vasquez C, Beatty PH, Lewis JD. PMID: 41998222 [PubMed - as supplied by publisher]
	MS-GATOR: multi-scale graph attention with topological reasoning for segmentation and classification of prostate cancer based on Gleason scores using histopathology images. Sci Rep Patil S, Swamy M, Sooda K, Vadigepalli R, Sattar KNA, Rafeeq M. PMID: 41998185 [PubMed - as supplied by publisher]
	Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer Rotterdam. Eur J Cancer Westerhout SF, Remmers S, Bangma CH, van Leenders GJLH, van Leeuwen PJ, Roobol MJ, ERSPC Rotterdam Study Group. PMID: 41997039 [PubMed - as supplied by publisher]
	Predicting High-Dose-Rate Brachytherapy Boost Benefit Using Hypoxia and Angiogenesis Gene Expression in Localised Prostate Cancer. Clin Oncol (R Coll Radiol) Lodhi T, Reardon M, Quiles CG, Rojas AM, Choudhury A, Hoskin P. PMID: 41996829 [PubMed - as supplied by publisher]
	Features and molecular genetic study of low-grade oncocytic tumor of the kidney. Ann Diagn Pathol Zhao J, Wang Y, Huang J, Jin X, Cai Y, Lu Y, Jiang T, Gan W. PMID: 41996739 [PubMed - as supplied by publisher]
	Is there an optimal sequential order to androgen receptor axis therapeutics? Clin Adv Hematol Oncol Alex J, Graff JN. PMID: 41996675 [PubMed - indexed for MEDLINE]
	Body Size and Bladder Cancer Risk: A Pooled Analysis of Prospective Studies From the National Cancer Institute Cohort Consortium. J Clin Oncol Pooling Project of Prospective Studies of Diet and Cancer. PMID: 41996653 [PubMed - as supplied by publisher]
	Promptable segmentation with region exploration enables minimal-effort expert-level prostate cancer delineation. Int J Comput Assist Radiol Surg Yang J, Thorley N, Abbasi AN, Punwani S, Tse Z, Hu Y, Saeed SU. PMID: 41996003 [PubMed - as supplied by publisher]
	Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features. Prostate Shimomura T, Murakami M, Kasai K, Imai Y, Inaba Y, Urabe F, Muramoto K, Yanagisawa T, Fukuokaya W, Keiichiro Mori, Tashiro K, Matsukawa A, Katsumi K, Takahashi H, Yoshihara K, Miyajima K, Iwatani K, Kayano S, Igarashi T, Tsuzuki S, Yamada H, Miki J, Kimura T. PMID: 41995698 [PubMed - as supplied by publisher]
	A nurse-led cross-sectional latent profile analysis of fear of cancer recurrence in patients with non-muscle-invasive bladder cancer. Medicine (Baltimore) Hao Y, Niu L, Shih YA, Gao P, Wu Y, Song W, Li C. PMID: 41995514 [PubMed - indexed for MEDLINE]
	Early recurrence after primary TURBT for non-muscle-invasive bladder cancer in Iceland: the critical role of surgical quality. Scand J Urol Björnsson O, Geirsson G, Leifsson ÁS, Nikulásson SÞ, Guðjónsson S. PMID: 41995346 [PubMed - indexed for MEDLINE]
	Application of the International Bladder Cancer Group prediction model for recurrence-free survival on a national cohort of primary intermediate risk non-muscle invasive bladder cancer. Scand J Urol Mesinovic D, Bobjer J, Hagberg O, Aljabery F, Gårdmark T, Jahnson S, Jerlström T, Kjölhede H, Malmström PU, Ströck V, Söderkvist K, Ullén A, Holmberg L, Häggström C, Liedberg F. PMID: 41995252 [PubMed - indexed for MEDLINE]
	Early Initiation of novel hormonal therapy is associated with improved survival in synchronous bone-metastatic hormone-sensitive prostate cancer: a retrospective cohort study from China. Front Oncol Guo Y, Jia Y, Fan Y, Zhang W, Li Y, Li Y. PMID: 41994659 [PubMed]
	Case Report: Prostate adenocarcinoma with peritoneal carcinomatosis and elevated CEA mimicking colorectal cancer: a diagnostic dilemma. Front Oncol Majeed H, Shelman N, Patel JA, Veedu JS, Selene II, Whitesell A, Myint ZW. PMID: 41994658 [PubMed]
	Redefining standards: a comprehensive systematic review of practice changing advances in GU oncology from ASCO and ESMO 2025. Front Endocrinol (Lausanne) Ismaili N. PMID: 41993992 [PubMed - indexed for MEDLINE]
	Phase I dose-escalation study of [Â¹â·â·Lu]Lu-LNC1011, a long-circulating dansyl-modified PSMA theranostics, in metastatic castration-resistant prostate cancer. Theranostics Wang J, Wang R, Xiang J, Yang H, Zhao T, Guo F, Liang Y, Zhu Z, Zhang J. PMID: 41993609 [PubMed - indexed for MEDLINE]
	Apalutamide-induced severe cutaneous adverse reactions in prostate cancer: a comprehensive review of reported cases and clinical strategies. Front Pharmacol Wang T, Liu S, Yuan R. PMID: 41993591 [PubMed]
	Mechanistic study of MUC3A in promoting progression of clear cell renal cell carcinoma via the JAKâ€‘STAT pathway. Oncol Rep Yun Y, Ji X, Hu S, Wu T, Liu Y, Li Z, Sun Z, Zhou P, Yang L, Yu W. PMID: 41992986 [PubMed - indexed for MEDLINE]
	Novel therapeutic strategies for metastatic castrationâ€‘resistant prostate cancer: Beyond androgen receptor pathway inhibition (Review). Int J Oncol Wang Y, Xie Y, Zhao Q. PMID: 41992975 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 177593

Seite 1 von 8880

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung